The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability
Open accessAbstract
Transactive response DNA-binding (TDP-43) protein is the dominant disease protein in amyotrophic lateral sclerosis (ALS) and a subgroup of frontotemporal lobar degeneration (FTLD-TDP). Identification of mutations in the gene encoding TDP-43 ( TARDBP ) in familial ALS confirms a mechanistic link between misaccumulation of TDP-43 and neurodegeneration and provides an opportunity to study TDP-43 proteinopathies in human neurons generated from patient fibroblasts by using induced pluripotent stem cells (iPSCs). Here, we report the generation of iPSCs that carry the TDP-43 M337V mutation and their differentiation into neurons and functional motor neurons. Mutant neurons had elevated levels of soluble and detergent-resistant TDP-43 protein, decreased survival in longitudinal studies, and increased vulnerability to antagonism of the PI3K pathway. We conclude that expression of physiological levels of TDP-43 in human neurons is sufficient to reveal a mutation-specific cell-autonomous phenotype and strongly supports this approach for the study of disease mechanisms and for drug screening.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Familial ALS patient iPSC-derived motor neurons with TDP-43 mutation showed decreased voltage-activated Na+ and K+ currents and increased vulnerability [39].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [39]
Experimental — accuracy not yet measuredIn the citing paper
“iPSC-derived motor neurons harboring the ALS-associated TARDBPM337V mutation demonstrate an accumulation of insoluble mutant TARDBP at native expression levels [298]”
From Autophagy and ALS: mechanistic insights and therapeutic implications (2022) · cites this paper as [298]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576
Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling
Chambers, S. M., Fasano, C. A., Papapetrou, E. P., Tomishima, M., Sadelain, M., & Studer, L. (2009) · Nature Biotechnology · doi:10.1038/nbt.1529 · Cited by 3,620
Arai, T., Hasegawa, M., Akiyama, H., Ikeda, K., Nonaka, T., Mori, H., Mann, D., Tsuchiya, K., Yoshida, M., Hashizume, Y., et al. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.093 · Cited by 2,732
TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis
Sreedharan, J., Blair, I. P., Tripathi, V. B., Hu, X., Vance, C., Rogelj, B., Ackerley, S., Durnall, J. C., Williams, K. L., Buratti, E., et al. (2008) · Science · doi:10.1126/science.1154584 · Cited by 2,630
Self-citationReprogramming of human somatic cells to pluripotency with defined factors
Park, I.-H., Zhao, R., West, J. A., Yabuuchi, A., Huo, H., Ince, T. A., Lerou, P. H., Lensch, M. W., & Daley, G. Q. (2008) · Nature · doi:10.1038/nature06534 · Cited by 2,436
Self-citationDimos, J. T., Rodolfa, K. T., Niakan, K. K., Weisenthal, L. M., Mitsumoto, H., Chung, W. K., Croft, G. F., Saphier, G., Leibel, R. L., Goland, R., et al. (2008) · Science · doi:10.1126/science.1158799 · Cited by 2,019
Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death
Arrasate, M., Mitra, S., Schweitzer, E. S., Segal, M. R., & Finkbeiner, S. (2004) · Nature · doi:10.1038/nature02998 · Cited by 1,979
Self-citationDirected differentiation of embryonic stem cells into motor neurons.
Wichterle, H., Lieberam, I., Porter, J. A., & Jessell, T. (2002) · Cell · doi:10.1016/s0092-8674(02)00835-8 · Cited by 1,792
Cited by
Sorted by citations
Items 201–300 of 331
Azpurua, J., Elkarim, E. A., Tranquille, M., & Dubnau, J. (2021) · PLoS Genetics · doi:10.1371/journal.pgen.1009882 · Cited by 17
Jacobs, B. M. (2014) · Journal of Parkinson s Disease · doi:10.3233/jpd-130268 · Cited by 18
Importance of being Nernst: Synaptic activity and functional relevance in stem cell-derived neurons
Bradford, A. B. (2015) · World Journal of Stem Cells · doi:10.4252/wjsc.v7.i6.899 · Cited by 17
The translational potential of human induced pluripotent stem cells for clinical neurology
Devine, H. E., & Patani, R. (2016) · Cell Biology and Toxicology · doi:10.1007/s10565-016-9372-7 · Cited by 18
Motor neurons derived from ALS-related mouse iPS cells recapitulate pathological features of ALS
Park, J.-H., Park, H.-S., Hong, S., & Kang, S. (2016) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.113 · Cited by 17
Ochałek, A., Szczęsna, K., Petazzi, P., Kobolák, J., & Dinnyés, A. (2016) · Stem Cells International · doi:10.1155/2016/5838934 · Cited by 17
Skibinski, G., & Finkbeiner, S. M. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.02.043 · Cited by 16
Self-citationStem cells and Neurodegenerative Diseases: Where is it All Going?
Barker, R. A. (2012) · Regenerative Medicine · doi:10.2217/rme.12.64 · Cited by 16
Advances in Huntington Disease Drug Discovery: Novel Approaches to Model Disease Phenotypes
Bard, J., Wall, M. D., Lazari, O., Arjomand, J., & Muñoz-Sanjuán, I. (2013) · SLAS DISCOVERY · doi:10.1177/1087057113510320 · Cited by 17
Identification of TCERG1 as a new genetic modulator of TDP-43 production in Drosophila
Pons, M., Prieto‐Sánchez, S., Miguel, L., Frébourg, T., Campion, D., Suñé, C., & Lecourtois, M. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0639-5 · Cited by 16
ALS, a cellular whodunit on motor neuron degeneration
Karagiannis, P., & Inoue, H. (2020) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2020.103524 · Cited by 16
High content analysis in amyotrophic lateral sclerosis
Rinaldi, F., Motti, D., Ferraiuolo, L., & Kaspar, B. K. (2016) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2016.12.001 · Cited by 17
Ustyantseva, E., Pavlova, S. V., Malakhova, A. A., Ustyantsev, K., Zakian, S. M., & Medvedev, S. P. (2022) · Scientific Reports · doi:10.1038/s41598-022-12807-z · Cited by 15
Rojas, F., Aguilar, R., Almeida, S., Fritz, E., Corvalán, D., Ampuero, E., Abarzúa, S., Garcés, P., Amaro, A., Diaz, I., et al. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1226604 · Cited by 15
Schork, N. J., & Nazor, K. L. (2017) · Advances in genetics · doi:10.1016/bs.adgen.2017.06.001 · Cited by 16
Crompton, L., McComish, S. F., Stathakos, P., Llana, O. C., Lane, J. D., & Caldwell, M. A. (2021) · Journal of Visualized Experiments · doi:10.3791/62095 · Cited by 14
Crook, J. M., Wallace, G. G., & Tomaskovic‐Crook, E. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.1013096 · Cited by 15
Exploring Motor Neuron Diseases Using iPSC Platforms
Johns, A. E., & Maragakis, N. J. (2022) · Stem Cells · doi:10.1093/stmcls/sxab006 · Cited by 14
Induced Pluripotent Stem Cells: Global Research Trends
Negoro, T., Okura, H., & Matsuyama, A. (2017) · BioResearch open access · doi:10.1089/biores.2017.0013 · Cited by 15
Pathogenic TDP-43 in amyotrophic lateral sclerosis
Chong, Z. Z., & Souayah, N. (2025) · Drug Discovery Today · doi:10.1016/j.drudis.2025.104351 · Cited by 13
TDP-43 proteinopathy in oligodendrocytes revealed using an induced pluripotent stem cell model
Barton, S. K., Magnani, D., James, O. G., Livesey, M. R., Selvaraj, B. T., James, O. T., Perkins, E., Gregory, J. M., Cleary, E. M., Ausems, C. R. M., et al. (2021) · Brain Communications · doi:10.1093/braincomms/fcab255 · Cited by 12
Self-citationRamic, M., Andrade, N. S., Rybin, M. J., Esanov, R., Wahlestedt, C., Benatar, M. G., & Zeier, Z. R. (2021) · Brain Sciences · doi:10.3390/brainsci11111543 · Cited by 12
The genetic basis of amyotrophic lateral sclerosis: recent breakthroughs
Robberecht, W., & Eykens, C. (2015) · Advances in Genomics and Genetics · doi:10.2147/agg.s57397 · Cited by 14
Isobe, T., Tooi, N., Nakatsuji, N., & Aiba, K. (2015) · Stem Cell Research · doi:10.1016/j.scr.2015.09.006 · Cited by 12
Doege, C. A., & Abeliovich, A. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.01.007 · Cited by 11
Nucleosome dynamics of human iPSC during neural differentiation
Harwood, J. C., Kent, N. A., Allen, N. D., & Harwood, A. J. (2019) · EMBO Reports · doi:10.15252/embr.201846960 · Cited by 11
Ahmed, M. E., Muffat, J., & Li, Y. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1158373 · Cited by 12
Investigating pediatric disorders with induced pluripotent stem cells
Durbin, M. D., Cadar, A. G., Chun, Y. W., & Hong, C. C. (2018) · Pediatric Research · doi:10.1038/s41390-018-0064-2 · Cited by 11
Bardelli, D., Sassone, F., Colombrita, C., Volpe, C., Gumina, V., Peverelli, S., Catusi, I., Ratti, A., Silani, V., & Bossolasco, P. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15048 · Cited by 11
Eglen, R. M., & Reisine, T. (2018) · SLAS TECHNOLOGY · doi:10.1177/2472630318803277 · Cited by 11
Atmaramani, R., Dreossi, T., Ford, K., Gan, L., Mitchell, J. M., Tu, S., Velayutham, J., Zeng, H., Chickering, M., Soare, T., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.04.574270 · Cited by 12
Review: Induced pluripotent stem cell models of frontotemporal dementia
Preza, E., Hardy, J., Warner, T. T., & Wray, S. (2016) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12334 · Cited by 10
Induced Pluripotent Stem Cell-Based Studies of Parkinson's Disease: Challenges and Promises
Sánchez‐Danés, A., Benzoni, P., Memo, M., Dell`Era, P., Raya, Á., & Consiglio, A. (2013) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152731131200128 · Cited by 11
Induced pluripotent stem cells and neurological disease models.
Cai, S., Chan, Y.-S., & Shum, D. K.-Y. (2014) · PubMed · doi:10.13294/j.aps.2014.0008 · Cited by 9
Developmental anatomy of the primary olfactory pathway in the opossum Monodelphis domestica.
Chuah, M. I., Tennent, R., & Teague, R. (1997) · PubMed · Cited by 10
Disease Modeling Studies Using Induced Pluripotent Stem Cells: Are we Using Enough Controls?
Johnson, A. A., Andrews-Pfannkoch, C. M., Nelson, T. J., Pulido, J. S., & Marmorstein, A. D. (2017) · Regenerative Medicine · doi:10.2217/rme-2017-0101 · Cited by 9
Onodera, O., Sugai, A., Konno, T., Tada, M., Koyama, A., & Nishizawa, M. (2013) · Neurology and Clinical Neuroscience · doi:10.1002/ncn3.9 · Cited by 8
iPSC-Based Models to Unravel Key Pathogenetic Processes Underlying Motor Neuron Disease Development
Faravelli, I., Frattini, E., Ramirez, A., Stuppia, G., Nizzardo, M., & Corti, S. P. (2014) · Journal of Clinical Medicine · doi:10.3390/jcm3041124 · Cited by 8
Cellular reprogramming: A new way to understand aging mechanisms
İlçe, B. Y., Cagin, U., & Yılmazer, A. (2018) · Wiley Interdisciplinary Reviews Developmental Biology · doi:10.1002/wdev.308 · Cited by 8
Crompton, L., Llana, O. C., & Caldwell, M. A. (2017) · Brain Pathology · doi:10.1111/bpa.12522 · Cited by 8
Comment on “Drug Screening for ALS Using Patient-Specific Induced Pluripotent Stem Cells”
Bilican, B., Serio, A., Barmada, S. J., Nishimura, A. L., Sullivan, G. J., Carrasco, M. A., Phatnani, H. P., Puddifoot, C. A., Story, D., Fletcher, J. M., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005065 · Cited by 8
Self-citationOrganellomics: AI-driven deep organellar phenotyping reveals novel ALS mechanisms in human neuronsPreprint
Krispin, S., van Zuiden, W., Danino, Y. M., Rudberg, N., Molitor, L., Abarbanel, B., Aviram, G., Wolf, G., Bar, C., Siani, A., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.31.572110 · Cited by 8
A next-generation HDAC6 inhibitor for amyotrophic lateral sclerosis and frontotemporal dementia
James, R. E., Bekier, M. E., Lee, P., Schroeder, F. A., Evans, L. J., Wagner, F. F., Hickman, D., Richardson, T., Hatzipetros, T., Vieira, F. G., et al. (2025) · Brain · doi:10.1093/brain/awaf380 · Cited by 7
Self-citationLiu, Z., Qiang, Y., Shan, S., Wang, S., & Song, F. (2024) · Cerebral Cortex · doi:10.1093/cercor/bhad526 · Cited by 7
Deriving, regenerating, and engineering CNS tissues using human pluripotent stem cells
Lemke, K. A., Aghayee, A., & Ashton, R. S. (2017) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2017.05.010 · Cited by 8
Jones, A. R. C., Edwards, D. H., Cummins, M. J., Williams, A. J., & George, C. H. (2016) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2015.00089 · Cited by 7
Andoh-Noda, T., Akamatsu, W., Miyake, K., Kobayashi, T., Ohyama, M., Kurosawa, H., Kubota, T., & Okano, H. (2016) · The Keio Journal of Medicine · doi:10.2302/kjm.2016-0015-oa · Cited by 7
Human iPSC Models in Drug Discovery: Opportunities and Challenges
Silva, M. C., Cross, A., Brandon, N. J., & Haggarty, S. J. (2017) · Comprehensive Medicinal Chemistry III · doi:10.1016/b978-0-12-409547-2.12284-x · Cited by 6
Rsp5/NEDD4 and ESCRT regulate TDP-43 toxicity and turnover via an endolysosomal clearance mechanism
Byrd, A. T., Marmorale, L. J., Marcinowski, S., Dykstra, M. M., Addison, V., Barmada, S. J., & Buchan, J. R. (2025) · The Journal of Cell Biology · doi:10.1083/jcb.202212064 · Cited by 7
Self-citationExperimental and Therapeutic Opportunities for Stem Cells in Multiple Sclerosis
Patani, R., & Chandran, S. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms131114470 · Cited by 6
Self-citationFunctional genomics, genetic risk profiling and cell phenotypes in neurodegenerative disease
Finkbeiner, S. M. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105088 · Cited by 8
Self-citationLiu, W.-C., Liu, N., Wang, Y., Huang, C., Li, Y., Wang, H., Li, X., & Deng, M. (2021) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001693 · Cited by 6
Hedges, E. C., Cocks, G. D., Shaw, C. E., & Nishimura, A. L. (2023) · Genes · doi:10.3390/genes14051108 · Cited by 6
Self-citationValetdinova, K. R., Medvedev, S. P., & Zakian, S. M. (2015) · Acta Naturae · doi:10.32607/20758251-2015-7-1-19-36 · Cited by 6
Patrón, L. A., ICAGEN, 2. E. I. P. D., & August, P. R. (2018) · AIMS Cell and Tissue Engineering · doi:10.3934/celltissue.2018.2.91 · Cited by 6
Egawa, N., Kitaoka, S., Tsukita, K., Naitoh, M., Takahashi, K., Yamamoto, T., Adachi, F., Kondo, T., Okita, K., Asaka, I., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005697 · Cited by 6
Induced Pluripotent Stem Cells as a Novel Tool in Psychiatric Research
Kim, S., Kim, M., Oh, D., Lee, S., & Kim, B. (2016) · Psychiatry Investigation · doi:10.4306/pi.2016.13.1.8 · Cited by 5
ALS disease modeling and drug screening using patient-specific iPS cells
Egawa, N., & Inoue, H. (2013) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.53.1020 · Cited by 5
Drug Screening and Validation Targeting TDP-43 Proteinopathy for Amyotrophic Lateral Sclerosis
Xin, J., Huang, S., Wen, J., Li, Y., Li, A., Satyanarayanan, S. K., Yao, X., & Su, H. (2024) · Aging and Disease · doi:10.14336/ad.2024.0440 · Cited by 4
Intersecting impact of CAG repeat and huntingtin knockout in stem cell-derived cortical neurons
Stocksdale, J. T., Leventhal, M. J., Lam, S., Xu, Y., Wang, Y., Wang, K. Q., Thomas, R., Faghihmonzavi, Z., Raghav, Y., Smith-Geater, C., et al. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106914 · Cited by 6
Self-citationTDP-43 impairs glycolysis by sequestering hexokinase 1 in amyotrophic lateral sclerosis
Barone, C., Wang, R., Cooke, S., Ng, H. P., Ferreira, R. S., Miranda, H. C., & Qi, X. (2026) · Acta Neuropathologica · doi:10.1007/s00401-026-02996-6 · Cited by 3
S-acylation of TDP43 regulates its condensation in amyotrophic lateral sclerosis
Xu, W., Li, H. F., Zhang, W., Bai, G., Shen, C., & Zhang, K. (2026) · Molecular Cell · doi:10.1016/j.molcel.2026.04.016 · Cited by 3
Bustos, L. M., & Sattler, R. (2023) · Frontiers in Molecular Medicine · doi:10.3389/fmmed.2023.1075805 · Cited by 4
Neuromuscular disease: new insights and avenues for therapy
Scotter, E. L., & Shaw, C. E. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70298-3 · Cited by 3
Self-citationHeterogeneity in Human Embryonic Stem Cells May Prevent Endodermal Guided Differentiation
Surajlata, S. K. K. (2015) · Journal of Stem Cell Research & Therapy · doi:10.4172/2157-7633.1000255 · Cited by 3
‘Body-on-a-Chip’ Technology and Supporting Microfluidics
Smith, A. S. T., Long, C. J., McAleer, C. W., Guo, X., Esch, M. B., Prot, J. M., Shuler, M. L., & Hickman, J. J. (2014) · Royal Society of Chemistry eBooks · doi:10.1039/9781782620136-00132 · Cited by 3
Chen, Q., Zhou, J., Huang, C., Huang, B., Bi, F., Zhou, H., & Xiao, B. (2018) · Current Neurovascular Research · doi:10.2174/1567202615666180109161541 · Cited by 3
Targeting TDP-43 Proteinopathy in hiPSC-Derived Mutated hNPCs with Mitoxantrone Drugs and miRNAs
Ansari, U. A., Srivastava, A., Srivastava, A. K., Pandeya, A., Vatsa, P., Negi, R., Singh, A., & Pant, A. B. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17040410 · Cited by 2
Doxakis, E., Xue, Y. C., & Savulescu, A. F. (2025) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2025.1716825 · Cited by 2
Chikuchi, R., Kato, Y., Tomatsu, A., Nishisaki, S., Kawakami, Y., Yoshimura, T., Li, J., Iguchi, Y., Onodera, K., Hashimoto, R., et al. (2025) · Neuroscience Research · doi:10.1016/j.neures.2025.105003 · Cited by 2
Ferraiuolo, L., Meyer, K., & Kaspar, B. K. (2013) · InTech eBooks · doi:10.5772/56487 · Cited by 3
Misfolded Protein Linked Strategies Toward Biomarker Development for Neurodegenerative Diseases
Kumar, S., Narayanan, K., Mishra, S., Padmanabhan, P., Radda, G. K., & Gulyás, B. Z. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1232-4 · Cited by 2
Neural tissue microphysiological systems in the era of patient-derived pluripotent stem cells
Mungenast, A. E., Aron, R., White, J. D., Tardiff, D. F., & Raja, W. K. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813671-3.00009-8 · Cited by 2
Nishimoto, Y., Okano, H. J., Imai, T., Poole, A. J., Suzuki, N., Keirstead, H. S., & Okano, H. (2013) · Neurology and Clinical Neuroscience · doi:10.1002/ncn3.2 · Cited by 2
Mislocalization, aggregation formation and defect in proteolysis in ALS
Tsubota, A., Ichijo, H., & Homma, K. (2016) · AIMS molecular science · doi:10.3934/molsci.2016.2.246 · Cited by 2
Chun, C., Smith, A. S. T., Bothwell, M. A., & Mack, D. L. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.91388 · Cited by 2
Unpicking neurodegeneration in a dish with human pluripotent stem cells
Bilican, B., Serio, A., Shaw, C. E., Maniatis, T., & Chandran, S. (2013) · Cell Cycle · doi:10.4161/cc.25705 · Cited by 2
Self-citationO’Toole, K., Guetta, L., Urbanaviciute, P., Suklai, P., Wright, C., Fisher, T., Liddelow, S. A., Luisier, R., Marzi, S. J., & Serio, A. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.11.622998 · Cited by 3
Self-citationBarriers to Novel Therapeutics in Amyotrophic Lateral Sclerosis
Kobeleva, X., & Petri, S. (2013) · Neurodegenerative Disease Management · doi:10.2217/nmt.13.66 · Cited by 1
Cell and gene therapy for amyotrophic lateral sclerosis
Paris, A., & Lakatos, A. (2024) · Handbook of clinical neurology · doi:10.1016/b978-0-323-90120-8.00017-4 · Cited by 1
Sergeeva, O. S., Neklesova, M. V., Reushev, V. A., Artemov, A. V., Константинович, Т. К., Константинович, Т. К., Uversky, V. N., & Fonin, A. V. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.152808 · Cited by 2
White, M. A., Crowley, L., Massenzio, F., Li, X., Niblock, M., Milani, S., Coleman, M. P., Barmada, S. J., & Sreedharan, J. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05675-5 · Cited by 2
Self-citationPasho, E., Catanese, A., Kabashi, E., & Ciura, S. (2026) · Translational Neurodegeneration · doi:10.1186/s40035-026-00580-2 · Cited by 1
Indukált pluripotens őssejtek szerepe a neurológiai betegségek modellezésében
Balogh, Z., Réthelyi, J., & Molnár, M. J. (2015) · Orvosi Hetilap · doi:10.1556/650.2015.30179 · Cited by 1
Hore, S. K. G. (2015) · Journal of Tissue Science & Engineering · doi:10.4172/2157-7552.1000144 · Cited by 1
Modelling Neurodegenerative Diseases Using Human Pluripotent Stem Cells
Hall, V. J. (2016) · InTech eBooks · doi:10.5772/63521 · Cited by 1
Kumari, A., Chaudhary, A., & Haque, R. (2022) · Springer eBooks · doi:10.1007/978-981-16-8562-0_5 · Cited by 1
ALS patient-specific iPS cells
Inoue, H. (2012) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.52.1137 · Cited by 1
Cáceres, D., Torres, F., Castillo, C. A., Maureira, A., Franco-Campos, F. A., Osorio, M., Segovia, R., Tapia, J. C., & Carrasco, M. A. (2019) · International Journal of Morphology · doi:10.4067/s0717-95022019000401203 · Cited by 1
Self-citationInduced pluripotent stem cells as models of human neurodevelopmental disorders
Jourdon, A., Mariani, J., Scuderi, S., Amiri, A., Wu, F., Yuen, E. Y., Abyzov, A. S., & Vaccarino, F. M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-814409-1.00005-7 · Cited by 1
An Introduction to Cellular Reprogramming: The Plasticity of Cell Fates and Identities
Smith, K. P., Borowski, M., & Laning, J. C. (2014) · Wiley eBooks · doi:10.1002/9781118695746.ch8 · Cited by 1
A Tribute to Keith Campbell: The Birth of the First Clone of an Adult Vertebrate, “Dolly” the Sheep
Wilmut, I. (2013) · Cellular Reprogramming · doi:10.1089/cell.2013.ed01 · Cited by 1
Self-citationUsing patient-derived cell models to investigate the role of misfolded SOD1 in ALS
Forsgren, E. (2017) · DiVA at Umeå University (Umeå University) · Cited by 1
Nucleosome dynamics of human iPSC during the early stages of neurodevelopmentPreprint
Harwood, J. C., Kent, N. A., Allen, N. D., & Harwood, A. J. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/398792 · Cited by 1
White, M. A., Massenzio, F., Li, X., Coleman, M. P., Barmada, S. J., & Sreedharan, J. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.03.429569 · Cited by 2
Self-citationSanford, Z. (2015) · Marshall Journal of Medicine · doi:10.18590/mjm.2015.vol1.iss1.3
Aplicaciones médicas de las células pluripotentes inducidas paciente-específicas
Beltrán, O. I. (2013) · Revista Med · doi:10.18359/rmed.1162
Advances in Pluripotent and Adult Stem Cells for Eye Research
Peh, G. S. L., & Wong, R. C. B. (2014) · Stem cell biology and regenerative medicine · doi:10.1007/978-1-4939-0787-8_5
3) iPS Cell Technology for Neurodegenerative Disease
Inoue, H. (2013) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.102.2267
Metadata
- Authors
- Bilican, B., Serio, A., Barmada, S. J., Nishimura, A. L., Sullivan, G. J., Carrasco, M., Phatnani, H. P., Puddifoot, C. A., Story, D., Fletcher, J., Park, I.-H., Friedman, B. A., Daley, G. Q., Wyllie, D. J. A., Hardingham, G. E., Wilmut, I., Finkbeiner, S., Maniatis, T., Shaw, C. E., & Chandran, S.
- Affiliations
- MRC Centre for Regenerative Medicine (GB)
- Gladstone Institutes (US)
- King's College London (GB)
- Department of Biochemistry and Molecular Biophysics,Columbia University, New York, NY 10032;
- Columbia University (US)
- University of Edinburgh (GB)
- Yale University (US)
- Harvard University (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2012-03-26
- Volume
- 109
- Issue
- 15
- Pages
- 5803-5808
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC3326463
- OpenAlex
- W2131321387
- Cited by
- 328
- References
- 51
- Citations by year
- 2026: 7 · 2025: 9 · 2024: 9 · 2023: 13 · 2022: 15 · 2021: 15 · 2020: 15 · 2019: 22 · 2018: 20 · 2017: 21 · 2016: 43 · 2015: 38 · 2014: 37 · 2013: 45 · 2012: 18
- FWCI
- 28.99
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Queen Mary Research Online (Queen Mary University of London) (submittedVersion)
- Funders
- Wellcome Trust (089701)
- Motor Neurone Disease Association (CHANDRAN/MAR10/982-797, Chandran/Mar10/6751)
- Medical Research Council (MC_G1000733)
- Biotechnology and Biological Sciences Research Council
- National Institute of Neurological Disorders and Stroke (K08NS072233, R01NS039074)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- TDP-43, amyotrophic lateral sclerosis, frontotemporal lobar degeneration, TARDBP, induced pluripotent stem cells, iPSC-derived neurons, motor neurons, PI3K signaling, neurodegeneration, drug screening
- MeSH terms
- Adult, Cell Differentiation, Detergents, DNA-Binding Proteins, Female, Fibroblasts, Humans, Male, Middle Aged, Motor Neurons, Mutation, Organ Specificity, Solubility, Induced Pluripotent Stem Cells, TDP-43 Proteinopathies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
